NCT05379985 2025-11-12Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRevolution Medicines, Inc.Phase 1/2 Recruiting754 enrolled
NCT05288205 2025-04-04Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C MutationAllist Pharmaceuticals, Inc.Phase 1/2 Recruiting240 enrolled